INVEST: Increase Vaccine Uptake in Adolescent in Rural South

Sponsor
Duke University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04999267
Collaborator
University of South Carolina (Other)
2,080
2
2
16
1040
65

Study Details

Study Description

Brief Summary

The benefits of adolescent vaccines are well known for preventing meningococcal infection and human papillomavirus (HPV)-related pre-cancerous lesions. Yet, many adolescents in the United States (US) remain under-vaccinated, with vaccination rates among rural adolescents significantly lower than among their urban peers. In addition, there are urban-rural disparities in the coverage of HPV vaccine, particularly in Southern states like North and South Carolina, which currently fall below the Healthy People 2020 goal of ≥80% coverage. The goal of the proposed study is to evaluate the feasibility and preliminary efficacy of a school-based intervention for increasing vaccine uptake among adolescents in rural North and South Carolina.

Condition or Disease Intervention/Treatment Phase
  • Other: INVEST
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
2080 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
A Tailored School-based Intervention to INcrease VaccinE Uptake Among adoleScenTs (INVEST) in the Rural South
Actual Study Start Date :
Aug 31, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: INVEST Intervention

Other: INVEST
The intervention will consist of 3 primary components: 1) school nurse training and technical support for promoting adolescent vaccination (Tdap, MenACWY, HPV) and strengthening existing school nursing vaccination programming, 2) caregiver-targeted educational materials that are disseminated via school nurses, and 3) tools and resources to facilitate linkage to vaccination providers in the local community. Existing materials will be used in the intervention such as resources available from the Centers for Disease Control and Prevention and Middle School Health Starts Here tool kit from the National Association of School Nurses and the National HPV Roundtable. Technical support includes the study team working with local school nurses to identify educational materials available from national and statewide sources.

No Intervention: Control

The control arm will not receive the INVEST Intervention and will receive the usual vaccine information materials by the schools.

Outcome Measures

Primary Outcome Measures

  1. Change in the proportion of adolescents who ever received at least one dose of HPV vaccination in the intervention group after the intervention implementation compared with before intervention implementation [Baseline, 9 months]

    HPV vaccination status (received at least one versus no doses) of middle schoolers (grades 6, 7, 8) will be obtained from official vaccination records before and after intervention implementation.

Secondary Outcome Measures

  1. Change in the proportion of adolescents who have completed the HPV vaccination series (2 or 3 doses depending on age at vaccination initiation) in the intervention group after implementation compared with before intervention implementation [Baseline, 9 months]

    HPV vaccination status (received at least one versus no doses) of middle schoolers (grades 6, 7, 8) will be obtained from official vaccination records before and after intervention implementation.

  2. Difference in the post-intervention change in the proportion of adolescents who ever received at least one dose of HPV vaccination in the intervention group compared with the control group [Baseline, 9 months]

    County-level data on HPV vaccination from control and intervention groups will be extracted from state registries.

  3. Difference in the post-intervention change in the proportion of adolescents who have completed the HPV vaccination series (two or three doses depending on age at vaccination initiation) in the intervention group compared with the control group [Baseline, 9 months]

    County-level data on HPV vaccination from control and intervention groups will be extracted from state registries.

  4. Mean score representing fidelity of intervention across intervention schools. [9 months]

    Score items (0-100%) from a study specific checklist (Fidelity Checklist) will be completed by school nurses from intervention schools with a high score (100%) indicating more adherence to the study intervention and 0% indicating the worse score and less adherence to the study intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
11 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Students in the 6th, 7th or 8th grade attending public middle schools in Cherokee County, South Carolina or Rockingham County, North Carolina school districts

  • Adolescents in control counties in North and South Carolina.

Exclusion Criteria:
  • Individuals not able to consent for themselves

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rockingham County Public Schools Rockingham North Carolina United States 28379
2 Cherokee County Public Schools Gaffney South Carolina United States 29340

Sponsors and Collaborators

  • Duke University
  • University of South Carolina

Investigators

  • Principal Investigator: Emmanuel Walter, MD, MPH, Duke University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT04999267
Other Study ID Numbers:
  • Pro00101137
First Posted:
Aug 10, 2021
Last Update Posted:
Feb 11, 2022
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Duke University

Study Results

No Results Posted as of Feb 11, 2022